Skip to content
OpenCapital
Get started

Envoy Medical COCH Proceeds From Related Party Debt

Proceeds From Related Party Debt at other companies

Agrify Corporation logo
Agrify CorporationRYM
$72M—
SVC
Stellar V Capital Corp. Class A Ordinary SharesSVCC
$25K—
OS Therapies logo
OS TherapiesOSTX
$33.55K-39.8%
Ivanhoe Electric logo
Ivanhoe ElectricIE
$2.5M-50.0%
KRAKacquisition logo
KRAKacquisition KRAQ
$201.75K—
DWS
Dawson Geophysical CompanyDWSN
$4.25M+386%

Other financials

Income statement

See full
Revenue$39.0K-15.2%
Gross profit-$274.0K-52.2%
Operating income-$6.0M-16.7%
Net income-$4.4M+12.9%
EPS (diluted)-$0.08+72.4%

Balance sheet

See full
Cash & equivalents$25.3M+376%
Total debt$919.0K-2.8%
Total equity$10.2M+142%
Total assets$29.8M+187%

Cash flow

See full
Operating cash flow-$6.1M-62.7%
CapEx$172.0K—
Free cash flow-$5.9M-28.5%

Valuation

See full
Market cap$61M+83.5%
P/S260.7×+111×

Profitability

See full
Gross margin-310.7%+31.6pp
Operating margin-9,881.2%+805pp
Net margin-9,875.6%+771pp
FCF margin-7,626.6%-652pp

Returns & leverage

See full
Return on equity328.7%—
Debt / equity0.1×—
Current ratio2.3×+1.2×

Where this comes from

Reported directly by Envoy Medical in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromRelatedPartyDebt.

The official record: Envoy Medical’s 10-Q, filed July 31, 2025, on SEC EDGAR. View the filing →

Ask your AI about Envoy Medical's proceeds from related party debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Envoy Medical's proceeds from related party debt?
Envoy Medical (COCH) reported proceeds from related party debt of $5M in Q2 2025.
How has Envoy Medical's proceeds from related party debt changed year-over-year?
Envoy Medical's proceeds from related party debt increased by 100.0% year-over-year, from $2.5M to $5M.
What does proceeds from related party debt mean?
Reflects cash inflows received from loans or credit facilities provided by entities with a significant influence or ownership stake in the company. This metric highlights the company's reliance on internal or affiliated funding sources rather than public capital markets. It is a key indicator of liquidity support during periods where traditional financing may be unavailable.